Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarbani Ghosh

Showing results (11-20 of 211) with videos related to

Pageof 22
Sort By:
Indian Journal of Urology : IJU : Journal of the Urological Society of India|January 27, 2012
Palliation of dysphagia with radiotherapy for exophytic base tongue metastases in a case of renal cell carcinomaTabassum Wadasadawala, Prabhash Kumar, Jaiprakash Agarwal, et al.
Plos One|July 7, 2018
Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinomaTejpal Gupta, Sadhana Kannan, Sarbani Ghosh-Laskar, et al.
Diagnostic Cytopathology|August 26, 2015
Fine-needle aspiration cytology in a rare case of recurrent mucinous carcinoma of skin, displaying psammoma bodies on smearsBharat Rekhi, Kedar K Deodhar, Sarbani Ghosh Laskar, et al.
Journal of Cancer Research and Therapeutics|July 29, 2020
COVID-19 pandemic: Radiotherapy precautions and preparednessNaveen Mummudi, Anil Tibdewal, Sarbani Ghosh-Laskar, et al.
Head & Neck|March 6, 2014
Concomitant chemoradiotherapy versus altered fractionation radiotherapy in the radiotherapeutic management of locoregionally advanced head and neck squamous cell carcinoma: An adjusted indirect comparison meta-analysisTejpal Gupta, Sadhana Kannan, Sarbani Ghosh-Laskar, et al.
Oral Oncology|September 26, 2022
Concurrent chemoradiotherapy with cisplatin given once-a-week versus every-three weekly in head and neck squamous cell carcinoma: Non-inferior, equivalent, or superior?Tejpal Gupta, Sadhana Kannan, Sarbani Ghosh-Laskar, et al.
Journal of Pharmaceutical Sciences|June 11, 2011
A formulation-enabled preclinical efficacy assessment of a farnesoid X receptor agonist, GW4064, in hamsters and cynomolgus monkeysPo-Chang Chiang, David C Thompson, Sarbani Ghosh, et al.
Oral Oncology|July 31, 2024
Adjuvant therapy for intermediate risk factors in oral cancer: Can we reach a consensus?Somdipto Das, Sarbani Ghosh Laskar, Shubhda V Kane, et al.
Indian Journal of Palliative Care|August 17, 2018
Asymptomatic Cardiac Metastasis in a Diagnosed Case of Squamous Cell Carcinoma of the Middle Third of EsophagusH S Sachin, Preethi Shetty, C S Pramesh, et al.
Bulletin Du Cancer|August 27, 2005
High dose rate brachytherapy boost for primary nasopharyngeal carcinoma: preliminary results of an ongoing prospective studyRohit Malde, Jai Prakash Agarwal, Sarbani Ghosh Laskar, et al.
Pageof 22

Showing results (11-20 of 211) with videos related to

Sort By:
Pageof 22
Indian Journal of Urology : IJU : Journal of the Urological Society of India|January 27, 2012
Palliation of dysphagia with radiotherapy for exophytic base tongue metastases in a case of renal cell carcinomaTabassum Wadasadawala, Prabhash Kumar, Jaiprakash Agarwal, et al.
Plos One|July 7, 2018
Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinomaTejpal Gupta, Sadhana Kannan, Sarbani Ghosh-Laskar, et al.
Diagnostic Cytopathology|August 26, 2015
Fine-needle aspiration cytology in a rare case of recurrent mucinous carcinoma of skin, displaying psammoma bodies on smearsBharat Rekhi, Kedar K Deodhar, Sarbani Ghosh Laskar, et al.
Journal of Cancer Research and Therapeutics|July 29, 2020
COVID-19 pandemic: Radiotherapy precautions and preparednessNaveen Mummudi, Anil Tibdewal, Sarbani Ghosh-Laskar, et al.
Head & Neck|March 6, 2014
Concomitant chemoradiotherapy versus altered fractionation radiotherapy in the radiotherapeutic management of locoregionally advanced head and neck squamous cell carcinoma: An adjusted indirect comparison meta-analysisTejpal Gupta, Sadhana Kannan, Sarbani Ghosh-Laskar, et al.
Oral Oncology|September 26, 2022
Concurrent chemoradiotherapy with cisplatin given once-a-week versus every-three weekly in head and neck squamous cell carcinoma: Non-inferior, equivalent, or superior?Tejpal Gupta, Sadhana Kannan, Sarbani Ghosh-Laskar, et al.
Journal of Pharmaceutical Sciences|June 11, 2011
A formulation-enabled preclinical efficacy assessment of a farnesoid X receptor agonist, GW4064, in hamsters and cynomolgus monkeysPo-Chang Chiang, David C Thompson, Sarbani Ghosh, et al.
Oral Oncology|July 31, 2024
Adjuvant therapy for intermediate risk factors in oral cancer: Can we reach a consensus?Somdipto Das, Sarbani Ghosh Laskar, Shubhda V Kane, et al.
Indian Journal of Palliative Care|August 17, 2018
Asymptomatic Cardiac Metastasis in a Diagnosed Case of Squamous Cell Carcinoma of the Middle Third of EsophagusH S Sachin, Preethi Shetty, C S Pramesh, et al.
Bulletin Du Cancer|August 27, 2005
High dose rate brachytherapy boost for primary nasopharyngeal carcinoma: preliminary results of an ongoing prospective studyRohit Malde, Jai Prakash Agarwal, Sarbani Ghosh Laskar, et al.
Pageof 22